Fujirebio Diagnostics

Fujirebio Diagnostics is a leader in cancer biomarker assays and in vitro diagnostics. Their products support early detection and monitoring of disease, aiding clinicians in making informed treatment decisions.

Content by Fujirebio Diagnostics

Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G ?-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
| 2 min read
Page 1 of 1 - 1 Total Items
Current Magazine Issue Background Image

CURRENT ISSUE - April 2026

When Lab Innovation Meets Sustainability

Why Performance, Cost, and Environmental Impact Now Compete in Procurement

Lab Manager April 2026 Cover Image